Doo Hyun Chung

Doo Hyun Chung publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Doo Hyun Chung sits on this spectrum.

Doo Hyun Chung D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Doo Hyun Chung sits on this spectrum.

Overview

Best Publications

• Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

  Sae-Won Han;Tae-You Kim;Pil Gyu Hwang;Soohyun Jeong

  991
  Citations

• STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells

  Joo Eun Jung;Hyun Gyu Lee;Ik Hyun Cho;Doo Hyun Chung

  557
  Citations

• Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.

  June Koo Lee;Junehawk Lee;Sehui Kim;Soyeon Kim

  494
  Citations

• Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

  Sae-Won Han;Tae-You Kim;Yoon Kyung Jeon;Pil Gyu Hwang

  354
  Citations

• Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis

  E H Kang;E B Lee;E B Lee;K C Shin;C H Im

  281
  Citations

• Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis

  Hoibin Jeong;Sehui Kim;Beom-Ju Hong;Chan-Ju Lee

  267
  Citations

• Correlation between the Size of the Solid Component on Thin-Section CT and the Invasive Component on Pathology in Small Lung Adenocarcinomas Manifesting as Ground-Glass Nodules

  Kyung Hee Lee;Jin Mo Goo;Jin Mo Goo;Sang Joon Park;Sang Joon Park;Jae Yeon Wi

  266
  Citations

• Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration

  Chan Young Ock;Bhumsuk Keam;Sehui Kim;Ju Seog Lee

  265
  Citations

• High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.

  Heounjeong Go;Yoon Kyung Jeon;Hyo Jin Park;Sook-Whan Sung

  250
  Citations

• PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.

  Hyo Jin Park;Joon Seok Park;Joon Seok Park;Yun Hee Jeong;Jimin Son

  234
  Citations

• Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.

  Moon Young Kim;Jaemoon Koh;Sehui Kim;Sehui Kim;Heounjeong Go

  224
  Citations

• Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma

  Jake June-Koo Lee;Seongyeol Park;Hansol Park;Sehui Kim

  220
  Citations

• Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status.

  Su Jin Shin;Yoon Kyung Jeon;Pil Jong Kim;Yong Mee Cho

  220
  Citations

• Mechanisms of Acquired Resistance to AZD9291: A Mutation-Selective, Irreversible EGFR Inhibitor.

  Tae Min Kim;Tae Min Kim;Ahnah Song;Dong-Wan Kim;Dong-Wan Kim;Soyeon Kim

  220
  Citations

• Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.

  Sehui Kim;Moon Young Kim;Jaemoon Koh;Jaemoon Koh;Heounjeong Go

  219
  Citations

• Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability

  Hyun Jin Shin;Kwan Hyuck Baek;Ae Hwa Jeon;Moon Taek Park

  215
  Citations

• Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status.

  Jaemoon Koh;Heounjeong Go;Bhumsuk Keam;Moon Young Kim

  210
  Citations

• Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy-resistant non-small cell lung cancer†

  Sae-Won Han;Pil Gyu Hwang;Doo Hyun Chung;Dong-Wan Kim

  209
  Citations

• Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.

  Hyun Ju Lee;Young Tae Kim;Chang Hyun Kang;Binsheng Zhao

  205
  Citations

• Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer

  Soyeon Kim;Tae Min Kim;Tae Min Kim;Dong Wan Kim;Dong Wan Kim;Heounjeong Go

  200
  Citations

• Palliative chemotherapy for pulmonary pleomorphic carcinoma.

  Hyun Mi Bae;Hye Sook Min;Se Hoon Lee;Se Hoon Lee;Dong Wan Kim;Dong Wan Kim

  198
  Citations

• Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer.

  Jeong Ok Lee;Tae Min Kim;Tae Min Kim;Se Hoon Lee;Se Hoon Lee;Dong Wan Kim;Dong Wan Kim

  189
  Citations

• Psat1-Dependent Fluctuations in α-Ketoglutarate Affect the Timing of ESC Differentiation.

  In Young Hwang;Sojung Kwak;Sangho Lee;Sangho Lee;Hyunsoo Kim

  182
  Citations